| Financial Year |
March 31 2023 |
| Monetary Funds |
792,883,516.32 |
| Held-for-trading Financial Assets |
284,501.39 |
| Notes Receivable |
-- |
| Accounts Receivable |
315,677,081.02 |
| Advances to Suppliers |
17,550,932.79 |
| Other Receivables |
9,736,367.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
115,156,212.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
42,824,211.28 |
| Total Current Assets |
1,361,967,464.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
12,004,206.93 |
| Investment Properties |
-- |
| Fixed Assetes |
217,250,862.99 |
| Under-construction Projects |
393,060,789.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
99,989,272.97 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,420,424.68 |
| Deferred Income Tax Assets |
7,215,836.93 |
| Other Non-Current Assets |
201,004,666.97 |
| Sub-Total of Non-Current Assets |
937,304,637.37 |
| Total Assets |
2,299,272,102.09 |
| Short-Term Loans |
115,133,034.85 |
| Trading Financial liabilities |
828,571.42 |
| Notes Payable |
148,272,926.76 |
| Accounts Payable |
152,346,385.86 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,418,533.74 |
| Taxes Payable |
4,158,198.69 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
27,766,723.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
77,376,427.31 |
| Other Current Liabilities |
1,963,928.18 |
| Sub-Total of Current Liabilities |
549,583,384.98 |
| Long-term Loans |
199,584,490.16 |
| Bonds Payable |
416,546,164.97 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,910,510.81 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
624,179,021.52 |
| Total Liabilities |
1,173,762,406.50 |
| Paid-In Capital(Or Share Stock) |
176,764,425.00 |
| Capital Surplus |
590,013,285.81 |
| Surplus Reserve |
53,825,660.66 |
| LESS:Treasury Stock |
24,689,175.00 |
| Undistributed Profits |
263,558,458.13 |
| Minority Stockholder's Interest |
62,938,682.46 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,062,571,013.13 |
| Owner's Equity（Stockholder's Equity） |
1,125,509,695.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,299,272,102.09 |
